Main Article Content
Hematological Profile, Neonates, Pregnancy Induced Hypertension, Prevalence
Hypertensive disorders are the most prevalent pregnancy complications. Major pregnancy-related maternal morbidities are caused by preeclampsia toxemia. Preeclampsia increases neonatal morbidity and mortality. Hematological permutation is more common in neonates of hypertensive moms, especially those with preeclampsia, according to many studies.
Objective: To determine the frequency of hematological profile of neonates among women with pregnancy induced hypertension visiting to Liaquat National Hospital Karachi.
Place and Duration: This Cross-Sectional study was conducted at Department of Obstetrics and Gynecology, Liaquat National Hospital, Karachi, Pakistan from February 8, 2022 to August 7, 2022
Methods: All eligible patients who visited LNH, Karachi were studied. After discussing the study's process, drawbacks and benefits, informed consent was obtained. Our study took cord blood from all mothers soon after delivery by double-clamping and severing the cord in between the clamps, then putting the syringe at the placental end of the cord proximally and collecting 4 mL of cord blood. The newborns' blood was transferred to the hospital lab for hematological analysis. All obtained data were entered into the proforma at the end and used electronically for study.
Results: Mean maternal age was 28.4±5.5 years. Mean ± SD of neonatal age was 15.2±4.8 with C.I (14.30…….16.09) days. In distribution of gender of baby, 46 (40.4%) were male while 68 (59.6%) were female. Hematological profile of neonates showed neutropenia in 20 (17.5%) neonates, thrombocytopenia in 45 (39.5%) while polycythemia was noted in 9 (7.9%) neonates.
Conclusion: The most prevalent hematological profile was thrombocytopenia, followed by neutropenia and polycythemia. Since the sample originated from different parts of Pakistan, it can be generalized.
2. Bolat A, Gursel O, Kurekci E, Atay A, Ozcan O. Blood parameters changes in cord blood of newborns of hypertensive mothers. Eur J Pediatr. 2013;172(11):1501-9.
3. Sharma G, Nesin M, Feuerstein M, Bussel JB. Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies. Am J Perinatol. 2009;26(09):683-9.
4. Huang SC, Chang FM. The adverse effect on fetal hemogram by preeclampsia: marked anisocytosis with normocytic, normochromic erythrocythemia as well as thrombocytopenia. Early Human Develop. 1994;37(2):91-8.
5. Fraser SH, Tudehope DI. Neonatal neutropenia and thrombocytopenia following maternal hypertension. J Paediatr Child Health. 1996;32(1):31-4.
6. Okoye HC, Eweputanna LI, Korubo KI, Ejele OA. Effects of maternal hypertension on the neonatal haemogram in southern Nigeria: a case-control study. Malawi Med J. 2016;28 (4):174-8.
7. Al-bahadily AK, AL-Omrani A, Mohammed M. The effect of pregnancy induced hypertension on complete blood count of newborn. Int J Pediatr. 2017;5(9):5667-76.
8. Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Childhood Fetal Neonat Ed. 2003;88(5):F359-64.
9. Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Cunniff C, Browne ML. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res. 2018;110(19):1433-42.
10. Spiro L, Scemons D. Management of chronic and gestational hypertension of pregnancy: a guide for primary care nurse practitioners. Open Nurs J. 2018;12:180-3.
11. Holm L, Stucke-Brander T, Wagner S, Sandager P, Schlütter J, Lindahl C, et al. Automated blood pressure self-measurement station compared to office blood pressure measurement for first trimester screening of pre-eclampsia. Health Informatics J. 2019; 25(4):1815-24.
12. Miller MJ, Butler P, Gilchriest J, Taylor A, Lutgendorf MA. Implementation of a standardized nurse initiated protocol to manage severe hypertension in pregnancy. J Matern Fetal Neonatal Med. 2020;33(6):1008-14.
13. Dymara-Konopka W, Laskowska M, Oleszczuk J. Preeclampsia - current management and future approach. Curr Pharm Biotechnol. 2018;19(10):786-96.
14. Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222. Obstet Gynecol. 2020;135(6):1492-5.
15. Timpka S, Markovitz A, Schyman T, Mogren I, Fraser A, Franks PW, et al. Midlife development of type 2 diabetes and hypertension in women by history of hypertensive disorders of pregnancy. Cardiovasc Diabetol. 2018;17(1):124.
16. Catov JM, Countouris M, Hauspurg A. Hypertensive disorders of pregnancy and CVD prediction: accounting for risk accrual during the reproductive years. J Am Coll Cardiol. 2018;72(11):1264-6.
17. Yang YY, Fang YH, Wang X, Zhang Y, Liu XJ, Yin ZZ. A retrospective cohort study of risk factors and pregnancy outcomes in 14,014 Chinese pregnant women. Medicine (Baltimore). 2018;97(33):e11748.
18. Colussi G, Catena C, Driul L, Pezzutto F, Fagotto V, Darsiè D, et al. Secondary hyperparathyroidism is associated with postpartum blood pressure in preeclamptic women and normal pregnancies. J Hypertens. 2021;39(3):563-72.
19. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins— Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133(1):e26-50.
20. Ishikawa T, Obara T, Nishigori H, Miyakoda K, Ishikuro M, Metoki H, et al. Antihypertensives prescribed for pregnant women in Japan: prevalence and timing determined from a database of health insurance claims. Pharmacoepidemiol Drug Saf. 2018;27(12):1325-34.
21. Gonzalez Suarez ML, Kattah A, Grande JP, Garovic V. Renal disorders in pregnancy: core curriculum 2019. Am J Kidney Dis. 2019;73(1):119-30.
22. Katigbak C, Fontenot HB. A primer on the new guideline for the prevention, detection, evaluation, and management of hypertension. Nurs Womens Health. 2018;22(4):346- 54.
23. ACOG Practice Bulletin No. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1.
24. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44-52.
25. Smith GN, Pudwell J, Saade GR. Impact of the new American hypertension guidelines on the prevalence of postpartum hypertension. Am J Perinatol. 2019;36(4):440-2.
26. Hauspurg A, Sutton EF, Catov JM, Caritis SN. Aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. Hypertension. 2018;72(1):202-7.
27. Kam T, Alexander M. Drug-induced immune thrombocytopenia. J Pharm Pract. 2014;27 (5):430-9.